Latest Regulatory Milestones News

Memphasys Limited has secured a major scientific endorsement for its RoXsta™ antioxidant profiling system, positioning the technology for expanded clinical and agricultural applications.

White Cliff Minerals has secured a crucial Class A Land Use Permit for its Rae Copper Project in Nunavut, setting the stage for maiden drilling activities to begin in March 2025. This regulatory milestone follows a positive environmental screening and signals progress in unlocking high-grade copper potential.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.

MRG Metals has achieved a major milestone with the official approval and signing of the Corridor Central Heavy Mineral Sands mining licence in Mozambique, unlocking development potential for its world-class Koko Massava deposit.

Telix Pharmaceuticals has exceeded its full-year 2024 revenue guidance, driven by strong sales of its prostate cancer diagnostic Illuccix® and strategic pipeline advancements.

Australian Vanadium Limited has secured critical EPA approval for its Gabanintha Vanadium Project, marking a significant step toward construction and production within its broader Australian Vanadium Project.

4DMedical has landed a paid pilot contract with the US Department of Defense to deploy its CT:VQ™ lung imaging technology on active-duty personnel, marking a significant step before FDA submission and spotlighting a billion-dollar market opportunity.

QEM Limited secures a Controlled Action declaration for its Julia Creek Vanadium and Energy Project, unlocking a streamlined Environmental Impact Statement process through a bilateral agreement between Commonwealth and Queensland governments.

EBR Systems Inc. has responded to ASX's price query, denying any undisclosed information behind recent trading spikes and confirming compliance with listing rules. The company also flagged an upcoming FDA inspection announcement.